Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × cabozantinib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 66 Prostatic Neoplasms 20 Kidney Neoplasms 13 Carcinoma, Transitional Cell 7 Carcinoma, Non-Small-Cell Lung 7 Urinary Bladder Neoplasms 6 Neoplasm Metastasis 5 Clear-cell metastatic renal cell carcinoma 5 Ovarian Neoplasms 4 Carcinoma, Hepatocellular 4 Urethral Neoplasms 3 Triple Negative Breast Neoplasms 3 Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Brain Neoplasms 3 Urologic Neoplasms 2 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Penile Neoplasms 2 Pancreatic Neoplasms 2 Pain 2 Melanoma 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinoma 2 von Hippel-Lindau Disease 1 Wilms Tumor 1

Interventions

diacetamate 1 cabozantinib 1 Nutrition Assessment 1 Methods 1 Geriatric Assessment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04134390 2024-01-09

CABOMAYOR

Spanish Oncology Genito-Urinary Group

Phase 2 Completed

Frailty, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡